CRMA 1001
Alternative Names: CRMA-1001Latest Information Update: 04 Oct 2024
At a glance
- Originator Chroma Medicine
- Class Antivirals
- Mechanism of Action Gene expression modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Hepatitis B